CONMED (CNMD) Director Kim Kelderman Converts RSUs (500 Shares)

What Happened

• Director Kim Kelderman reported an exercise/conversion of a derivative on 2026-09-08. The filing shows 500 shares acquired at $0.00 and a simultaneous disposition of 500 shares at $0.00. Both entries are coded M (exercise or conversion of a derivative), indicating settlement of restricted stock units (RSUs) rather than a market purchase or cash sale. The reported dollar value for both transactions is $0.

Key Details

• Transaction date: 2026-09-08; Form 4 filed: 2026-09-10 (Accession: 0000816956-26-000105).
• Reported entries: 500 shares acquired @ $0.00 (M); 500 shares disposed @ $0.00 (M).
• Shares owned after the transaction: not provided in the excerpt.
• Footnote: F1 — Each RSU represents a contingent right to one share under the Company’s 2025 Long‑Term Incentive Plan; RSUs generally vest 100% after one year.
• No indication in the provided data that this filing was late.

Context

• These entries are consistent with RSU vesting/settlement: an insider receives shares upon conversion of RSUs (acquired at $0) and may have offsetting entries recorded simultaneously. The $0 price indicates no cash purchase; the activity is routine compensation-related settlement rather than a directional buy or sell in the open market.